Adaptive Sleep Apnea Tx Risk in HF 'Real'

ACC Conference Reporter

ESC 2015 | LONDON — The surprising mortality risk from central sleep apnea treatment in systolic heart failure (HF) appears real and more from sudden death than from chronic worsening, the SERVE-HF trial researchers suggested. Read More >>>

Keywords: ESC Congress

< Back to Listings